Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bangi Inc. is a diversified investment vehicle specializing in the acquisition and management of assets within the cannabis industry. The company primarily focuses on acquiring cannabis-related real estate, such as cultivation, manufacturing, and retail facilities, which it then leases back to licensed operators under long-term arrangements. Beyond real estate, Bangi seeks to invest in and develop cannabis brands and intellectual property to build a comprehensive portfolio in the legal cannabis space. By providing capital and infrastructure to operators, the company aims to consolidate a fragmented market and offer investors diversified exposure to the cannabis sector. Bangi's business model leverages the growing legalization of cannabis across various jurisdictions to generate revenue through lease agreements and brand licensing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bangi Investments.